Array 
AFN Sustainable Protein
DECEMBER 12, 2017
Dahl is President and CEO of ZIVO Bioscience , a ag biotech R&D company engaged in the commercialization of nutritional and medicinal products derived from proprietary algal strains. New Cultivation Technologies Make Algae Commercially Viable. Animal feed and supplements represent yet another opportunity.
AFN Sustainable Protein
DECEMBER 12, 2017
Dahl is President and CEO of ZIVO Bioscience , a ag biotech R&D company engaged in the commercialization of nutritional and medicinal products derived from proprietary algal strains. New Cultivation Technologies Make Algae Commercially Viable. Animal feed and supplements represent yet another opportunity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GreenBiz
MARCH 15, 2021
San Francisco Bay Area biotech giant Genentech is a world leader in making medicines for diseases such as cancer and cystic fibrosis; it’s even trialing one of its medicines for helping treat COVID-19. Retaining the best talent is crucial to Genentech’s ability to stay ahead with biotech innovation. Katie Fehrenbacher.
Business Green
JUNE 19, 2020
Clean technologies and infrastructure are now proven at scale and are broadly cost-competitive, while most of the world's governments and businesses are much more cognisant of escalating climate risks than they were back in 2008. The big question is how best to spend limited funds when so many early stage clean technologies require support.
AGreenLiving
MARCH 15, 2021
San Francisco Bay Area biotech giant Genentech is a world leader in making medicines for diseases such as cancer and cystic fibrosis; it’s even trialing one of its medicines for helping treat COVID-19. Retaining the best talent is crucial to Genentech’s ability to stay ahead with biotech innovation. And Genentech isn’t the only one.
Expert insights. Personalized for you.
52 
Let's personalize your content